Patents by Inventor Jakob Izbicki

Jakob Izbicki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12239795
    Abstract: A thoracic catheter for a comparatively simple and reliable control and relief of pain associated with thoracatomy. The thoracic catheter (1) has a distal end (2), a proximal end (3) and an intercostal region (4) in between. The thoracic catheter (1) is covered on its outer surface (6) in the intercostal region (4) with a capillary active layer (5), which is fluidically connectable to a distal source (7) of an anesthetic agent, and which, when arranged in the body of a patient, is capable of releasing the anesthetic agent into the intercostal space (21).
    Type: Grant
    Filed: January 20, 2020
    Date of Patent: March 4, 2025
    Assignee: Universitaetsklinikum Hamburg-Eppendorf
    Inventors: Asmus Heumann, Jakob Izbicki
  • Publication number: 20220062583
    Abstract: A thoracic catheter allowing a comparatively simple and reliable control and relief of pain associated with thoracatomy. The thoracic catheter (1) of the invention has a distal end (2), a proximal end (3) and an intercostal region (4) in between, wherein the thoracic catheter (1) is covered on its outer surface (6) in the intercostal region (4) with a capillary active layer (5), which is fluidically connectable to a distal source (7) of an anesthetic agent, and which, when arranged in the body of a patient, is capable of releasing the anesthetic agent into the intercostal space (21).
    Type: Application
    Filed: January 20, 2020
    Publication date: March 3, 2022
    Inventors: Asmus Heumann, Jakob Izbicki
  • Patent number: 7132288
    Abstract: Disclosed is a medium for cultivating tumor cells, comprising the following constituents, as comprised for example in the medium RPMI 1640: (a) fetal calf serum (FCS), (b) penicillin-streptomycin, (c) L-glutamine, (d) transferrin, (e) insulin, (f) human epidermal growth factor (EGF) and (g) ?-TGF. A method for characterizing tumor cells or potential tumor cells, respectively, is also described. Said method includes the culturing of cells in the inventive medium and the two tumor cell lines LNHOS1 and PTHOS1 established by means of the inventive culturing method.
    Type: Grant
    Filed: February 14, 2002
    Date of Patent: November 7, 2006
    Assignee: Uni-Klinikum Hamburg-Eppendorf
    Inventors: Jakob Izbicki, Stefan Hosch, Peter Scheunemann
  • Publication number: 20040067581
    Abstract: Disclosed is a medium for cultivating tumor cells, comprising the following constituents, as comprised for example in the medium RPMI 1640: (a) fetal calf serum (FCS), (b) penicillin-streptomycin, (c) L-glutamine, (d) transferrin, (e) insulin, (f) human epidermal growth factor (EGF) and (g) &agr;-TGF. A method for characterizing tumor cells or potential tumor cells, respectively, is also described. Said method includes the culturing of cells in the inventive medium and the two tumor cell lines LNHOS1 and PTHOS1 established by means of the inventive culturing method.
    Type: Application
    Filed: August 13, 2003
    Publication date: April 8, 2004
    Inventors: Jakob Izbicki, Stefan Hosch, Peter Scheunemann